Evidence map›Paper›PMID 41647228›Full record

ArticleArXiv2026

Simulations Predict Improved Valve Performance Without Direct Leaflet Intervention After Neonatal Truncus Arteriosus Repair.

Karoline-Marie Bornemann, Perry S Choi, Jay Huber, Alexander K Reed, Amit Sharir, Shiraz A Maskatia, Alison L Marsden, Michael R Ma, Alexander D Kaiser

Abstract readPreprint
In one paragraph

Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Karoline-Marie Bornemann
Perry S Choi
Jay Huber
Alexander K Reed
Amit Sharir
Shiraz A Maskatia
Alison L Marsden
Michael R Ma
Alexander D Kaiser

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Truncus arteriosus (TA) is a rare and severe congenital heart disease. Quadricuspid valve morphology occurs in 25% of all TA patients and is linked to regurgitation and increased risk of re-operation. It remains unclear how hemodynamic changes after TA repair alter valve performance. This study simulated pre- and postoperative conditions in a neonatal TA patient to investigate valve performance without direct intervention. We hypothesize that valve performance before and after truncal repair can be predicted in-silico, matching in-vivo imaging and identifying mechanisms how hemodynamic changes after repair will reduce valve regurgitation without direct intervention. Pre- and postoperative CT images of a neonatal patient with quadricuspid valve were segmented. Free edge length and geometric height from the patient's echocardiogram were used to model the valve. For the preoperative condition, ventricular pressures were set equal modeling an unrestricted ventricular septal defect. Systemic and pulmonary resistances were tuned based on the patient's Qp:Qs ratio. For the postoperative condition, boundary conditions were modified to mimic patient-specific hemodynamics after TA repair. The preoperative simulation confirmed mild valve regurgitation seen in-vivo. Interaction between asymmetric flow and surrounding vessel resulted in asymmetric opening and closing. Poor central coaptation led to a central regurgitant jet toward the septum. Altered postoperative hemodynamics improved coaptation and eliminated regurgitation, as seen in-vivo. This modeling approach reproduced in-vivo pre- and postoperative valve performance and identified mechanisms improving coaptation after TA repair. TA repair led to elimination of regurgitation due to enhanced central coaptation. Thus, altered postoperative hemodynamic conditions after TA repair may improve valve performance without direct leaflet intervention.

Identifiers

PMID41647228
PMCPMC12869376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.